Acacia Pharma's Antiemetic Baremsis A Step Closer to US Filing

Acacia Pharma has taken another step towards filing its post-operative nausea and vomiting treatment Baremsis in the US with a second Phase III trial, this time in the treatment, rather than prevention, of the condition.